Skip to content

C84.67

Billable

Anaplastic large cell lymphoma, ALK-positive, spleen

HCC Category Mapping

V28HCC 20Lung and Other Severe Cancers
0.000
V24HCC 10Lymphoma and Other Cancers
0.675
ESRDHCC 10Lymphoma and Other Cancers
0.000
RxHCCHCC 21Hodgkin Lymphoma and Other Cancers
0.000

What This Code Means

This is a type of aggressive blood cancer that starts in immune cells and involves the spleen. It is characterized by the presence of a specific genetic abnormality (ALK-positive) that helps doctors identify and treat this particular form of lymphoma.

Coding Tips

  • Verify documentation confirms both the ALK-positive status and spleen involvement before assigning this code, as these are essential specificity requirements
  • Ensure the code is paired with appropriate staging information (typically codes from C84.6- series) and any relevant treatment codes to provide complete clinical picture

Clinical Significance

Anaplastic large cell lymphoma, ALK-positive, involving the spleen indicates splenic infiltration by this ALK-driven T-cell malignancy. Splenic involvement may present with splenomegaly, left upper quadrant pain, or cytopenias. Distinguishing this from hepatosplenic T-cell lymphoma is essential because the two entities have vastly different prognoses and treatment approaches.

Documentation Requirements

  • Pathology confirming ALCL with ALK positivity (not hepatosplenic T-cell lymphoma)
  • Imaging documenting splenic involvement (CT, ultrasound, or PET/CT)
  • CD30 positivity on immunohistochemistry
  • Splenectomy pathology if applicable
  • Clinical staging and disease extent

Commonly Confused Codes

Code Hierarchy

Open C84.67 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.